LamdaGen

About:

LamdaGen is a developer of nano-based plasmonic biosensors and robust diagnostic systems.

Website: http://www.lamdagen.com/

Top Investors: National Institute of Allergy and Infectious Diseases

Description:

LamdaGen is a developer of nano-based plasmonic biosensors and robust diagnostic systems. The company is increasing access to healthcare with its L’AuRa diagnostic platform, a game-changing technology. L’AuRa is an immuno-based platform that combines the high sensitivity and precision of ELISA with the simplicity and speed of lateral flow to enable quantitative and rapid detection of diseases, pathogens and contaminants. LamdaGen licenses its L’AuRa technology to companies in the human diagnostic, companion animal and food safety industries.